CURE Magazine seeks HCC patients on immunotherapy

[AndreaWilson_Founder]

Independent journalist Sonya Collins is writing a story on immunotherapy for liver cancer. She would like to interview HCC patients taking Pembrolizumab (Keytruda) or Nivolumab (Opdivo). The deadline for the interview is Friday, April 12.

If you are interested in participating, please contact Sonya directly via email at: [e-mail]. (View her website at sonyacollins.net)

*There is no compensation for the interview. Blue Faery is not responsible for the actions or writing of an independent journalist.